| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
1993-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b17a854307695755a1bb90dd8385dc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf8ccb111d607d52dd07027f7fcbf792 |
| publicationDate |
1993-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0568437-A1 |
| titleOfInvention |
Antidepressant 3-Halophenylpiperazinyl-propyl Derivatives of Substituted Triazolones and Triazoldiones |
| abstract |
Compounds of Formula In n or a pharmaceutically acceptable acid addition salt and/or hydrate thereof whereinn R is halogen and trifluoromethyl; X is oxygen and acetyl; nthe single and dotted lines represent either a covalent single or double bond; n is an integer from 2 to 4; and Z is hydrogen andn in which R¹ is hydrogen, halogen, C₁ - ₄ alkoxy and trifluoromethyl, which nare psychotropic agents having promise as antidepressants by virtue of their receptor site binding affinity profiles and animal pharmacology. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104402842-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6124294-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6403593-B1 |
| priorityDate |
1992-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |